nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—ALB—melanoma	0.238	1	CbGaD
Sevoflurane—ALB—Vemurafenib—melanoma	0.117	0.359	CbGbCtD
Sevoflurane—CYP2E1—Dacarbazine—melanoma	0.0926	0.285	CbGbCtD
Sevoflurane—CYP3A4—Temozolomide—melanoma	0.0668	0.205	CbGbCtD
Sevoflurane—CYP3A4—Vemurafenib—melanoma	0.0366	0.113	CbGbCtD
Sevoflurane—CYP3A4—Docetaxel—melanoma	0.0126	0.0386	CbGbCtD
Sevoflurane—ATP2C1—skin epidermis—melanoma	0.00589	0.0702	CbGeAlD
Sevoflurane—Electrocardiogram QT prolonged—Vemurafenib—melanoma	0.00582	0.0339	CcSEcCtD
Sevoflurane—Intracranial pressure increased—Carmustine—melanoma	0.00473	0.0275	CcSEcCtD
Sevoflurane—ATP2C1—hair follicle—melanoma	0.0042	0.0501	CbGeAlD
Sevoflurane—ND1—neck—melanoma	0.00354	0.0423	CbGeAlD
Sevoflurane—GABRE—hair follicle—melanoma	0.00314	0.0375	CbGeAlD
Sevoflurane—GRIA1—eye—melanoma	0.00307	0.0366	CbGeAlD
Sevoflurane—GRIA1—retina—melanoma	0.00304	0.0362	CbGeAlD
Sevoflurane—KCNA1—retina—melanoma	0.00296	0.0354	CbGeAlD
Sevoflurane—Atrial fibrillation—Vemurafenib—melanoma	0.00286	0.0167	CcSEcCtD
Sevoflurane—GABRA3—neck—melanoma	0.00286	0.0341	CbGeAlD
Sevoflurane—KCNK10—head—melanoma	0.00239	0.0285	CbGeAlD
Sevoflurane—KCNK9—head—melanoma	0.00238	0.0284	CbGeAlD
Sevoflurane—ND1—skin of body—melanoma	0.00229	0.0274	CbGeAlD
Sevoflurane—Wheezing—Bleomycin—melanoma	0.0022	0.0128	CcSEcCtD
Sevoflurane—KCNK3—head—melanoma	0.00216	0.0257	CbGeAlD
Sevoflurane—Leukocytosis—Carmustine—melanoma	0.0021	0.0122	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Temozolomide—melanoma	0.0021	0.0122	CcSEcCtD
Sevoflurane—ATP2C1—retina—melanoma	0.00208	0.0248	CbGeAlD
Sevoflurane—Respiratory failure—Temozolomide—melanoma	0.00194	0.0113	CcSEcCtD
Sevoflurane—GABRQ—head—melanoma	0.00192	0.023	CbGeAlD
Sevoflurane—ATP2C1—skin of body—melanoma	0.00182	0.0218	CbGeAlD
Sevoflurane—Cardiac disorder—Vemurafenib—melanoma	0.00174	0.0101	CcSEcCtD
Sevoflurane—GRIA1—head—melanoma	0.00174	0.0208	CbGeAlD
Sevoflurane—Hepatic failure—Dactinomycin—melanoma	0.0017	0.00992	CcSEcCtD
Sevoflurane—Angiopathy—Vemurafenib—melanoma	0.0017	0.00991	CcSEcCtD
Sevoflurane—KCNA1—head—melanoma	0.0017	0.0203	CbGeAlD
Sevoflurane—Mediastinal disorder—Vemurafenib—melanoma	0.00169	0.00984	CcSEcCtD
Sevoflurane—ATP5D—mammalian vulva—melanoma	0.00169	0.0201	CbGeAlD
Sevoflurane—GABRG3—head—melanoma	0.00169	0.0201	CbGeAlD
Sevoflurane—Chills—Vemurafenib—melanoma	0.00168	0.0098	CcSEcCtD
Sevoflurane—ATP2C1—mammalian vulva—melanoma	0.00166	0.0198	CbGeAlD
Sevoflurane—GABRA4—mammalian vulva—melanoma	0.00164	0.0196	CbGeAlD
Sevoflurane—Malnutrition—Vemurafenib—melanoma	0.00163	0.0095	CcSEcCtD
Sevoflurane—Dysgeusia—Vemurafenib—melanoma	0.0016	0.00931	CcSEcCtD
Sevoflurane—KCNK2—lymph node—melanoma	0.00157	0.0187	CbGeAlD
Sevoflurane—Hepatic failure—Temozolomide—melanoma	0.00154	0.00898	CcSEcCtD
Sevoflurane—ND1—head—melanoma	0.0015	0.0178	CbGeAlD
Sevoflurane—Chest discomfort—Docetaxel—melanoma	0.00143	0.00835	CcSEcCtD
Sevoflurane—Cough—Vemurafenib—melanoma	0.00142	0.00829	CcSEcCtD
Sevoflurane—Liver function test abnormal—Dactinomycin—melanoma	0.00141	0.00823	CcSEcCtD
Sevoflurane—Bone disorder—Docetaxel—melanoma	0.00141	0.00818	CcSEcCtD
Sevoflurane—Bronchospasm—Bleomycin—melanoma	0.0014	0.00813	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Docetaxel—melanoma	0.0014	0.00813	CcSEcCtD
Sevoflurane—GABRD—head—melanoma	0.0014	0.0166	CbGeAlD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00138	0.00804	CcSEcCtD
Sevoflurane—Oliguria—Docetaxel—melanoma	0.00138	0.00802	CcSEcCtD
Sevoflurane—GABRG1—head—melanoma	0.00134	0.016	CbGeAlD
Sevoflurane—GABRA6—head—melanoma	0.00134	0.0159	CbGeAlD
Sevoflurane—Anaphylactic shock—Vemurafenib—melanoma	0.00133	0.00776	CcSEcCtD
Sevoflurane—GABRB3—eye—melanoma	0.00133	0.0159	CbGeAlD
Sevoflurane—Liver function test abnormal—Carmustine—melanoma	0.00132	0.00771	CcSEcCtD
Sevoflurane—Nervous system disorder—Vemurafenib—melanoma	0.00131	0.00761	CcSEcCtD
Sevoflurane—GABRB1—head—melanoma	0.0013	0.0155	CbGeAlD
Sevoflurane—GABRA5—head—melanoma	0.0013	0.0155	CbGeAlD
Sevoflurane—Skin disorder—Vemurafenib—melanoma	0.00129	0.00753	CcSEcCtD
Sevoflurane—Respiratory failure—Docetaxel—melanoma	0.00129	0.00752	CcSEcCtD
Sevoflurane—Hypotension—Vemurafenib—melanoma	0.00125	0.00725	CcSEcCtD
Sevoflurane—GABRE—mammalian vulva—melanoma	0.00124	0.0149	CbGeAlD
Sevoflurane—GABRA3—head—melanoma	0.00121	0.0144	CbGeAlD
Sevoflurane—ATP5D—head—melanoma	0.00121	0.0144	CbGeAlD
Sevoflurane—ATP2C1—head—melanoma	0.00119	0.0142	CbGeAlD
Sevoflurane—GABRA4—head—melanoma	0.00118	0.014	CbGeAlD
Sevoflurane—GABRP—head—melanoma	0.00117	0.0139	CbGeAlD
Sevoflurane—Gastrointestinal disorder—Vemurafenib—melanoma	0.00115	0.0067	CcSEcCtD
Sevoflurane—Haemoglobin—Bleomycin—melanoma	0.00114	0.00665	CcSEcCtD
Sevoflurane—Haemorrhage—Bleomycin—melanoma	0.00114	0.00661	CcSEcCtD
Sevoflurane—Dysuria—Temozolomide—melanoma	0.00112	0.00652	CcSEcCtD
Sevoflurane—Hyperglycaemia—Carmustine—melanoma	0.00112	0.00651	CcSEcCtD
Sevoflurane—Renal failure—Carmustine—melanoma	0.00109	0.00632	CcSEcCtD
Sevoflurane—Hyperglycaemia—Temozolomide—melanoma	0.00108	0.00629	CcSEcCtD
Sevoflurane—Hepatitis—Dactinomycin—melanoma	0.00106	0.00617	CcSEcCtD
Sevoflurane—Body temperature increased—Vemurafenib—melanoma	0.00105	0.00613	CcSEcCtD
Sevoflurane—Pharyngitis—Dactinomycin—melanoma	0.00105	0.00612	CcSEcCtD
Sevoflurane—ND1—lymph node—melanoma	0.00105	0.0125	CbGeAlD
Sevoflurane—Hepatic failure—Docetaxel—melanoma	0.00103	0.00597	CcSEcCtD
Sevoflurane—Chills—Bleomycin—melanoma	0.00102	0.00594	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Temozolomide—melanoma	0.00101	0.00588	CcSEcCtD
Sevoflurane—Haemoglobin—Carmustine—melanoma	0.000997	0.0058	CcSEcCtD
Sevoflurane—Haemorrhage—Carmustine—melanoma	0.000992	0.00577	CcSEcCtD
Sevoflurane—GABRB2—head—melanoma	0.000983	0.0117	CbGeAlD
Sevoflurane—GABRG2—head—melanoma	0.000983	0.0117	CbGeAlD
Sevoflurane—Hypersensitivity—Vemurafenib—melanoma	0.000982	0.00571	CcSEcCtD
Sevoflurane—Atrial fibrillation—Docetaxel—melanoma	0.000972	0.00566	CcSEcCtD
Sevoflurane—Haemoglobin—Temozolomide—melanoma	0.000963	0.00561	CcSEcCtD
Sevoflurane—Hepatitis—Temozolomide—melanoma	0.000959	0.00558	CcSEcCtD
Sevoflurane—Haemorrhage—Temozolomide—melanoma	0.000959	0.00558	CcSEcCtD
Sevoflurane—Asthenia—Vemurafenib—melanoma	0.000956	0.00557	CcSEcCtD
Sevoflurane—Pharyngitis—Temozolomide—melanoma	0.000951	0.00554	CcSEcCtD
Sevoflurane—Chills—Dactinomycin—melanoma	0.000951	0.00554	CcSEcCtD
Sevoflurane—Urinary tract disorder—Temozolomide—melanoma	0.000947	0.00551	CcSEcCtD
Sevoflurane—Pruritus—Vemurafenib—melanoma	0.000943	0.00549	CcSEcCtD
Sevoflurane—Urethral disorder—Temozolomide—melanoma	0.00094	0.00547	CcSEcCtD
Sevoflurane—GABRA2—head—melanoma	0.000898	0.0107	CbGeAlD
Sevoflurane—GABRE—head—melanoma	0.000891	0.0106	CbGeAlD
Sevoflurane—Cardiac disorder—Temozolomide—melanoma	0.00089	0.00518	CcSEcCtD
Sevoflurane—Arrhythmia—Carmustine—melanoma	0.000886	0.00516	CcSEcCtD
Sevoflurane—Dizziness—Vemurafenib—melanoma	0.000881	0.00513	CcSEcCtD
Sevoflurane—Angiopathy—Temozolomide—melanoma	0.00087	0.00506	CcSEcCtD
Sevoflurane—Mental disorder—Carmustine—melanoma	0.000869	0.00506	CcSEcCtD
Sevoflurane—GABRA1—head—melanoma	0.000868	0.0104	CbGeAlD
Sevoflurane—Immune system disorder—Temozolomide—melanoma	0.000866	0.00504	CcSEcCtD
Sevoflurane—Mediastinal disorder—Temozolomide—melanoma	0.000864	0.00503	CcSEcCtD
Sevoflurane—Malnutrition—Carmustine—melanoma	0.000863	0.00503	CcSEcCtD
Sevoflurane—Cough—Bleomycin—melanoma	0.000863	0.00502	CcSEcCtD
Sevoflurane—Chills—Temozolomide—melanoma	0.00086	0.00501	CcSEcCtD
Sevoflurane—Liver function test abnormal—Docetaxel—melanoma	0.000851	0.00495	CcSEcCtD
Sevoflurane—Vomiting—Vemurafenib—melanoma	0.000847	0.00493	CcSEcCtD
Sevoflurane—ATP5D—lymph node—melanoma	0.000844	0.0101	CbGeAlD
Sevoflurane—Chest pain—Bleomycin—melanoma	0.000842	0.0049	CcSEcCtD
Sevoflurane—Rash—Vemurafenib—melanoma	0.00084	0.00489	CcSEcCtD
Sevoflurane—Mental disorder—Temozolomide—melanoma	0.00084	0.00489	CcSEcCtD
Sevoflurane—Dermatitis—Vemurafenib—melanoma	0.000839	0.00489	CcSEcCtD
Sevoflurane—Headache—Vemurafenib—melanoma	0.000835	0.00486	CcSEcCtD
Sevoflurane—Malnutrition—Temozolomide—melanoma	0.000834	0.00486	CcSEcCtD
Sevoflurane—ATP2C1—lymph node—melanoma	0.000833	0.00994	CbGeAlD
Sevoflurane—Dysgeusia—Temozolomide—melanoma	0.000817	0.00476	CcSEcCtD
Sevoflurane—Confusional state—Bleomycin—melanoma	0.000814	0.00474	CcSEcCtD
Sevoflurane—Anaphylactic shock—Bleomycin—melanoma	0.000807	0.0047	CcSEcCtD
Sevoflurane—Oedema—Bleomycin—melanoma	0.000807	0.0047	CcSEcCtD
Sevoflurane—Agitation—Carmustine—melanoma	0.000793	0.00462	CcSEcCtD
Sevoflurane—Nausea—Vemurafenib—melanoma	0.000791	0.00461	CcSEcCtD
Sevoflurane—Thrombocytopenia—Bleomycin—melanoma	0.00079	0.0046	CcSEcCtD
Sevoflurane—CYP2B6—skin of body—melanoma	0.000784	0.00936	CbGeAlD
Sevoflurane—Bronchospasm—Docetaxel—melanoma	0.000783	0.00456	CcSEcCtD
Sevoflurane—Agitation—Temozolomide—melanoma	0.000767	0.00446	CcSEcCtD
Sevoflurane—GABRB3—head—melanoma	0.000755	0.00901	CbGeAlD
Sevoflurane—Hypotension—Bleomycin—melanoma	0.000754	0.00439	CcSEcCtD
Sevoflurane—Oedema—Dactinomycin—melanoma	0.000753	0.00438	CcSEcCtD
Sevoflurane—Convulsion—Carmustine—melanoma	0.000748	0.00436	CcSEcCtD
Sevoflurane—Hypertension—Carmustine—melanoma	0.000745	0.00434	CcSEcCtD
Sevoflurane—Thrombocytopenia—Dactinomycin—melanoma	0.000737	0.00429	CcSEcCtD
Sevoflurane—Chest pain—Carmustine—melanoma	0.000735	0.00428	CcSEcCtD
Sevoflurane—Cough—Temozolomide—melanoma	0.000728	0.00424	CcSEcCtD
Sevoflurane—Convulsion—Temozolomide—melanoma	0.000723	0.00421	CcSEcCtD
Sevoflurane—Hypertension—Temozolomide—melanoma	0.00072	0.00419	CcSEcCtD
Sevoflurane—Dyspnoea—Bleomycin—melanoma	0.00072	0.00419	CcSEcCtD
Sevoflurane—Confusional state—Carmustine—melanoma	0.000711	0.00414	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000705	0.00411	CcSEcCtD
Sevoflurane—Oedema—Carmustine—melanoma	0.000705	0.0041	CcSEcCtD
Sevoflurane—Renal failure—Docetaxel—melanoma	0.000698	0.00406	CcSEcCtD
Sevoflurane—Dry mouth—Temozolomide—melanoma	0.000695	0.00404	CcSEcCtD
Sevoflurane—Jaundice—Docetaxel—melanoma	0.000692	0.00403	CcSEcCtD
Sevoflurane—Pain—Bleomycin—melanoma	0.00069	0.00402	CcSEcCtD
Sevoflurane—Conjunctivitis—Docetaxel—melanoma	0.00069	0.00402	CcSEcCtD
Sevoflurane—Thrombocytopenia—Carmustine—melanoma	0.00069	0.00402	CcSEcCtD
Sevoflurane—Tachycardia—Carmustine—melanoma	0.000688	0.004	CcSEcCtD
Sevoflurane—Confusional state—Temozolomide—melanoma	0.000687	0.004	CcSEcCtD
Sevoflurane—Oedema—Temozolomide—melanoma	0.000681	0.00396	CcSEcCtD
Sevoflurane—Anaphylactic shock—Temozolomide—melanoma	0.000681	0.00396	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Docetaxel—melanoma	0.000672	0.00391	CcSEcCtD
Sevoflurane—Nervous system disorder—Temozolomide—melanoma	0.000668	0.00389	CcSEcCtD
Sevoflurane—Thrombocytopenia—Temozolomide—melanoma	0.000667	0.00388	CcSEcCtD
Sevoflurane—Feeling abnormal—Bleomycin—melanoma	0.000665	0.00387	CcSEcCtD
Sevoflurane—Skin disorder—Temozolomide—melanoma	0.000661	0.00385	CcSEcCtD
Sevoflurane—Hypotension—Carmustine—melanoma	0.000658	0.00383	CcSEcCtD
Sevoflurane—Pain—Dactinomycin—melanoma	0.000644	0.00375	CcSEcCtD
Sevoflurane—Urticaria—Bleomycin—melanoma	0.000641	0.00373	CcSEcCtD
Sevoflurane—Haemoglobin—Docetaxel—melanoma	0.000641	0.00373	CcSEcCtD
Sevoflurane—Body temperature increased—Bleomycin—melanoma	0.000638	0.00372	CcSEcCtD
Sevoflurane—Hepatitis—Docetaxel—melanoma	0.000637	0.00371	CcSEcCtD
Sevoflurane—Haemorrhage—Docetaxel—melanoma	0.000637	0.00371	CcSEcCtD
Sevoflurane—Insomnia—Carmustine—melanoma	0.000637	0.00371	CcSEcCtD
Sevoflurane—Pharyngitis—Docetaxel—melanoma	0.000633	0.00368	CcSEcCtD
Sevoflurane—Urinary tract disorder—Docetaxel—melanoma	0.00063	0.00366	CcSEcCtD
Sevoflurane—GABRA2—lymph node—melanoma	0.000629	0.0075	CbGeAlD
Sevoflurane—Dyspnoea—Carmustine—melanoma	0.000628	0.00366	CcSEcCtD
Sevoflurane—Somnolence—Carmustine—melanoma	0.000626	0.00365	CcSEcCtD
Sevoflurane—Urethral disorder—Docetaxel—melanoma	0.000625	0.00364	CcSEcCtD
Sevoflurane—GABRE—lymph node—melanoma	0.000624	0.00744	CbGeAlD
Sevoflurane—Feeling abnormal—Dactinomycin—melanoma	0.00062	0.00361	CcSEcCtD
Sevoflurane—Insomnia—Temozolomide—melanoma	0.000616	0.00359	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Carmustine—melanoma	0.000608	0.00354	CcSEcCtD
Sevoflurane—Dyspnoea—Temozolomide—melanoma	0.000607	0.00353	CcSEcCtD
Sevoflurane—Somnolence—Temozolomide—melanoma	0.000605	0.00352	CcSEcCtD
Sevoflurane—Pain—Carmustine—melanoma	0.000603	0.00351	CcSEcCtD
Sevoflurane—Body temperature increased—Dactinomycin—melanoma	0.000595	0.00346	CcSEcCtD
Sevoflurane—Hypersensitivity—Bleomycin—melanoma	0.000595	0.00346	CcSEcCtD
Sevoflurane—Cardiac disorder—Docetaxel—melanoma	0.000592	0.00344	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Temozolomide—melanoma	0.000588	0.00342	CcSEcCtD
Sevoflurane—Pain—Temozolomide—melanoma	0.000582	0.00339	CcSEcCtD
Sevoflurane—Feeling abnormal—Carmustine—melanoma	0.000581	0.00338	CcSEcCtD
Sevoflurane—Asthenia—Bleomycin—melanoma	0.000579	0.00337	CcSEcCtD
Sevoflurane—Angiopathy—Docetaxel—melanoma	0.000578	0.00337	CcSEcCtD
Sevoflurane—Immune system disorder—Docetaxel—melanoma	0.000576	0.00335	CcSEcCtD
Sevoflurane—Mediastinal disorder—Docetaxel—melanoma	0.000574	0.00334	CcSEcCtD
Sevoflurane—Chills—Docetaxel—melanoma	0.000572	0.00333	CcSEcCtD
Sevoflurane—Pruritus—Bleomycin—melanoma	0.000571	0.00332	CcSEcCtD
Sevoflurane—Arrhythmia—Docetaxel—melanoma	0.000569	0.00331	CcSEcCtD
Sevoflurane—ALB—lymph node—melanoma	0.000569	0.00678	CbGeAlD
Sevoflurane—Feeling abnormal—Temozolomide—melanoma	0.000561	0.00327	CcSEcCtD
Sevoflurane—Mental disorder—Docetaxel—melanoma	0.000558	0.00325	CcSEcCtD
Sevoflurane—Body temperature increased—Carmustine—melanoma	0.000557	0.00324	CcSEcCtD
Sevoflurane—Malnutrition—Docetaxel—melanoma	0.000555	0.00323	CcSEcCtD
Sevoflurane—Hypersensitivity—Dactinomycin—melanoma	0.000555	0.00323	CcSEcCtD
Sevoflurane—Dysgeusia—Docetaxel—melanoma	0.000543	0.00316	CcSEcCtD
Sevoflurane—Urticaria—Temozolomide—melanoma	0.000541	0.00315	CcSEcCtD
Sevoflurane—Asthenia—Dactinomycin—melanoma	0.00054	0.00314	CcSEcCtD
Sevoflurane—Body temperature increased—Temozolomide—melanoma	0.000538	0.00313	CcSEcCtD
Sevoflurane—Hypersensitivity—Carmustine—melanoma	0.000519	0.00302	CcSEcCtD
Sevoflurane—Vomiting—Bleomycin—melanoma	0.000513	0.00299	CcSEcCtD
Sevoflurane—CYP2B6—head—melanoma	0.000512	0.00611	CbGeAlD
Sevoflurane—Rash—Bleomycin—melanoma	0.000509	0.00296	CcSEcCtD
Sevoflurane—Dermatitis—Bleomycin—melanoma	0.000509	0.00296	CcSEcCtD
Sevoflurane—Asthenia—Carmustine—melanoma	0.000506	0.00294	CcSEcCtD
Sevoflurane—Hypersensitivity—Temozolomide—melanoma	0.000502	0.00292	CcSEcCtD
Sevoflurane—Syncope—Docetaxel—melanoma	0.000498	0.0029	CcSEcCtD
Sevoflurane—Asthenia—Temozolomide—melanoma	0.000489	0.00284	CcSEcCtD
Sevoflurane—Loss of consciousness—Docetaxel—melanoma	0.000488	0.00284	CcSEcCtD
Sevoflurane—Cough—Docetaxel—melanoma	0.000484	0.00282	CcSEcCtD
Sevoflurane—Pruritus—Temozolomide—melanoma	0.000482	0.0028	CcSEcCtD
Sevoflurane—Convulsion—Docetaxel—melanoma	0.000481	0.0028	CcSEcCtD
Sevoflurane—CYP2E1—head—melanoma	0.00048	0.00573	CbGeAlD
Sevoflurane—Nausea—Bleomycin—melanoma	0.00048	0.00279	CcSEcCtD
Sevoflurane—Hypertension—Docetaxel—melanoma	0.000479	0.00279	CcSEcCtD
Sevoflurane—Vomiting—Dactinomycin—melanoma	0.000479	0.00279	CcSEcCtD
Sevoflurane—Rash—Dactinomycin—melanoma	0.000475	0.00276	CcSEcCtD
Sevoflurane—Chest pain—Docetaxel—melanoma	0.000472	0.00275	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000469	0.00273	CcSEcCtD
Sevoflurane—Dizziness—Carmustine—melanoma	0.000466	0.00271	CcSEcCtD
Sevoflurane—Dry mouth—Docetaxel—melanoma	0.000462	0.00269	CcSEcCtD
Sevoflurane—Confusional state—Docetaxel—melanoma	0.000457	0.00266	CcSEcCtD
Sevoflurane—Anaphylactic shock—Docetaxel—melanoma	0.000453	0.00264	CcSEcCtD
Sevoflurane—Oedema—Docetaxel—melanoma	0.000453	0.00264	CcSEcCtD
Sevoflurane—Dizziness—Temozolomide—melanoma	0.00045	0.00262	CcSEcCtD
Sevoflurane—Vomiting—Carmustine—melanoma	0.000448	0.00261	CcSEcCtD
Sevoflurane—Nausea—Dactinomycin—melanoma	0.000447	0.0026	CcSEcCtD
Sevoflurane—Shock—Docetaxel—melanoma	0.000446	0.00259	CcSEcCtD
Sevoflurane—Rash—Carmustine—melanoma	0.000444	0.00259	CcSEcCtD
Sevoflurane—Nervous system disorder—Docetaxel—melanoma	0.000444	0.00259	CcSEcCtD
Sevoflurane—Dermatitis—Carmustine—melanoma	0.000444	0.00258	CcSEcCtD
Sevoflurane—Thrombocytopenia—Docetaxel—melanoma	0.000443	0.00258	CcSEcCtD
Sevoflurane—Tachycardia—Docetaxel—melanoma	0.000442	0.00257	CcSEcCtD
Sevoflurane—Headache—Carmustine—melanoma	0.000441	0.00257	CcSEcCtD
Sevoflurane—Skin disorder—Docetaxel—melanoma	0.00044	0.00256	CcSEcCtD
Sevoflurane—Vomiting—Temozolomide—melanoma	0.000433	0.00252	CcSEcCtD
Sevoflurane—Rash—Temozolomide—melanoma	0.000429	0.0025	CcSEcCtD
Sevoflurane—Dermatitis—Temozolomide—melanoma	0.000429	0.0025	CcSEcCtD
Sevoflurane—Headache—Temozolomide—melanoma	0.000427	0.00248	CcSEcCtD
Sevoflurane—Hypotension—Docetaxel—melanoma	0.000423	0.00246	CcSEcCtD
Sevoflurane—Nausea—Carmustine—melanoma	0.000419	0.00244	CcSEcCtD
Sevoflurane—Insomnia—Docetaxel—melanoma	0.00041	0.00238	CcSEcCtD
Sevoflurane—Nausea—Temozolomide—melanoma	0.000404	0.00235	CcSEcCtD
Sevoflurane—Dyspnoea—Docetaxel—melanoma	0.000404	0.00235	CcSEcCtD
Sevoflurane—Somnolence—Docetaxel—melanoma	0.000403	0.00234	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Docetaxel—melanoma	0.000391	0.00228	CcSEcCtD
Sevoflurane—Pain—Docetaxel—melanoma	0.000387	0.00225	CcSEcCtD
Sevoflurane—Feeling abnormal—Docetaxel—melanoma	0.000373	0.00217	CcSEcCtD
Sevoflurane—Body temperature increased—Docetaxel—melanoma	0.000358	0.00208	CcSEcCtD
Sevoflurane—Hypersensitivity—Docetaxel—melanoma	0.000334	0.00194	CcSEcCtD
Sevoflurane—Asthenia—Docetaxel—melanoma	0.000325	0.00189	CcSEcCtD
Sevoflurane—Pruritus—Docetaxel—melanoma	0.00032	0.00187	CcSEcCtD
Sevoflurane—Dizziness—Docetaxel—melanoma	0.000299	0.00174	CcSEcCtD
Sevoflurane—Vomiting—Docetaxel—melanoma	0.000288	0.00168	CcSEcCtD
Sevoflurane—Rash—Docetaxel—melanoma	0.000286	0.00166	CcSEcCtD
Sevoflurane—Dermatitis—Docetaxel—melanoma	0.000285	0.00166	CcSEcCtD
Sevoflurane—Headache—Docetaxel—melanoma	0.000284	0.00165	CcSEcCtD
Sevoflurane—Nausea—Docetaxel—melanoma	0.000269	0.00157	CcSEcCtD
Sevoflurane—CYP2E1—Metabolism—PIP4K2A—melanoma	3.75e-05	0.000207	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC6A11—melanoma	3.75e-05	0.000207	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MTAP—melanoma	3.73e-05	0.000206	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—HRAS—melanoma	3.72e-05	0.000205	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GPAM—melanoma	3.71e-05	0.000205	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	3.7e-05	0.000204	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—HRAS—melanoma	3.7e-05	0.000204	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—MAPK1—melanoma	3.68e-05	0.000203	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MTAP—melanoma	3.65e-05	0.000202	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.64e-05	0.000201	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—ALB—melanoma	3.64e-05	0.000201	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	3.63e-05	0.0002	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—MAPK1—melanoma	3.61e-05	0.000199	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—HRAS—melanoma	3.61e-05	0.000199	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—ALB—melanoma	3.59e-05	0.000198	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—HRAS—melanoma	3.56e-05	0.000196	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HDAC2—melanoma	3.55e-05	0.000196	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IGF1—melanoma	3.55e-05	0.000196	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—MAPK1—melanoma	3.55e-05	0.000196	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—MAPK1—melanoma	3.53e-05	0.000195	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CD44—melanoma	3.51e-05	0.000194	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—GNAQ—melanoma	3.51e-05	0.000194	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—ITGA4—melanoma	3.51e-05	0.000194	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNB1—melanoma	3.49e-05	0.000193	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—MAPK1—melanoma	3.46e-05	0.000191	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PLCB4—melanoma	3.43e-05	0.000189	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CD—melanoma	3.41e-05	0.000188	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CB—melanoma	3.41e-05	0.000188	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CB—melanoma	3.41e-05	0.000188	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNA1—melanoma	3.4e-05	0.000188	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTGS2—melanoma	3.38e-05	0.000186	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTGS2—melanoma	3.38e-05	0.000186	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—FASN—melanoma	3.37e-05	0.000186	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—HRAS—melanoma	3.37e-05	0.000186	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—IL6—melanoma	3.35e-05	0.000185	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—HRAS—melanoma	3.32e-05	0.000183	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PHGDH—melanoma	3.32e-05	0.000183	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—LUM—melanoma	3.32e-05	0.000183	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SYK—melanoma	3.3e-05	0.000182	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—ALB—melanoma	3.28e-05	0.000181	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—HPSE—melanoma	3.26e-05	0.00018	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PHGDH—melanoma	3.25e-05	0.00018	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—LUM—melanoma	3.25e-05	0.00018	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—ITGAV—melanoma	3.24e-05	0.000179	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT3—melanoma	3.24e-05	0.000179	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIP4K2A—melanoma	3.23e-05	0.000178	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC6A11—melanoma	3.23e-05	0.000178	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CUBN—melanoma	3.2e-05	0.000177	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—HPSE—melanoma	3.19e-05	0.000176	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—ALB—melanoma	3.19e-05	0.000176	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	3.17e-05	0.000175	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNA2—melanoma	3.17e-05	0.000175	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PLA2G6—melanoma	3.15e-05	0.000174	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	3.15e-05	0.000174	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MTAP—melanoma	3.14e-05	0.000173	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CUBN—melanoma	3.13e-05	0.000173	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—ALB—melanoma	3.13e-05	0.000173	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SDHD—melanoma	3.09e-05	0.00017	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—BSG—melanoma	3.09e-05	0.00017	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CSPG4—melanoma	3.09e-05	0.00017	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—ALB—melanoma	3.08e-05	0.00017	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.07e-05	0.000169	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—ALB—melanoma	3.06e-05	0.000169	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—HRAS—melanoma	3.04e-05	0.000168	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—MAPK1—melanoma	3.03e-05	0.000167	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SDHD—melanoma	3.03e-05	0.000167	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CSPG4—melanoma	3.03e-05	0.000167	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—BSG—melanoma	3.03e-05	0.000167	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	3e-05	0.000166	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GPAM—melanoma	2.99e-05	0.000165	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	2.97e-05	0.000164	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—HRAS—melanoma	2.95e-05	0.000163	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTEN—melanoma	2.95e-05	0.000163	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTEN—melanoma	2.95e-05	0.000163	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—ITGB1—melanoma	2.94e-05	0.000163	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GPAM—melanoma	2.93e-05	0.000162	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—HRAS—melanoma	2.9e-05	0.00016	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ACER3—melanoma	2.87e-05	0.000159	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—HRAS—melanoma	2.85e-05	0.000157	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—HRAS—melanoma	2.83e-05	0.000156	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—VCAN—melanoma	2.83e-05	0.000156	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PHGDH—melanoma	2.8e-05	0.000154	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—LUM—melanoma	2.8e-05	0.000154	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—HRAS—melanoma	2.78e-05	0.000153	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—HPSE—melanoma	2.74e-05	0.000151	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	2.73e-05	0.000151	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HGF—melanoma	2.69e-05	0.000149	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CUBN—melanoma	2.69e-05	0.000149	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CSF2—melanoma	2.66e-05	0.000147	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—UGT2B10—melanoma	2.63e-05	0.000145	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	2.62e-05	0.000145	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SDHD—melanoma	2.6e-05	0.000143	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—BSG—melanoma	2.6e-05	0.000143	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CSPG4—melanoma	2.6e-05	0.000143	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—ITGB3—melanoma	2.55e-05	0.000141	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PRKCA—melanoma	2.55e-05	0.000141	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PLA2G6—melanoma	2.54e-05	0.00014	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GPAM—melanoma	2.52e-05	0.000139	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PLA2G6—melanoma	2.49e-05	0.000137	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HS3ST5—melanoma	2.44e-05	0.000135	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—HRAS—melanoma	2.43e-05	0.000134	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	2.4e-05	0.000133	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP17A1—melanoma	2.39e-05	0.000132	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—RAC1—melanoma	2.37e-05	0.000131	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	2.32e-05	0.000128	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MMP1—melanoma	2.29e-05	0.000126	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—VCAN—melanoma	2.28e-05	0.000126	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GNA11—melanoma	2.26e-05	0.000125	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CDK2—melanoma	2.25e-05	0.000124	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—VCAN—melanoma	2.24e-05	0.000124	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—FASN—melanoma	2.21e-05	0.000122	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	2.19e-05	0.000121	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SLC5A5—melanoma	2.17e-05	0.00012	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PLA2G6—melanoma	2.14e-05	0.000118	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GNAQ—melanoma	2.1e-05	0.000116	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CD44—melanoma	2.1e-05	0.000116	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—FN1—melanoma	2.09e-05	0.000115	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	2.09e-05	0.000115	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CA—melanoma	2.08e-05	0.000115	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CA—melanoma	2.08e-05	0.000115	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NOS2—melanoma	2.06e-05	0.000114	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP1B1—melanoma	2.01e-05	0.000111	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CG—melanoma	2e-05	0.00011	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—EGF—melanoma	1.98e-05	0.000109	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP17A1—melanoma	1.93e-05	0.000106	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—VCAN—melanoma	1.92e-05	0.000106	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP17A1—melanoma	1.89e-05	0.000104	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PLCB4—melanoma	1.85e-05	0.000102	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IGF1—melanoma	1.83e-05	0.000101	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.82e-05	0.0001	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GNA11—melanoma	1.82e-05	0.0001	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.81e-05	0.0001	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GNA11—melanoma	1.78e-05	9.84e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—FASN—melanoma	1.78e-05	9.83e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CD—melanoma	1.76e-05	9.7e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.76e-05	9.7e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC5A5—melanoma	1.75e-05	9.67e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—FASN—melanoma	1.74e-05	9.63e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC6A11—melanoma	1.74e-05	9.61e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIP4K2A—melanoma	1.74e-05	9.61e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC5A5—melanoma	1.72e-05	9.47e-05	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKT1—melanoma	1.7e-05	9.37e-05	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKT1—melanoma	1.7e-05	9.37e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MTAP—melanoma	1.69e-05	9.35e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GNAQ—melanoma	1.69e-05	9.34e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CD44—melanoma	1.69e-05	9.34e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CD44—melanoma	1.66e-05	9.15e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GNAQ—melanoma	1.66e-05	9.15e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ABCB1—melanoma	1.66e-05	9.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP17A1—melanoma	1.62e-05	8.96e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP1B1—melanoma	1.62e-05	8.95e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.6e-05	8.83e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP1B1—melanoma	1.59e-05	8.77e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GNA11—melanoma	1.53e-05	8.46e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CB—melanoma	1.53e-05	8.46e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PRKCA—melanoma	1.52e-05	8.41e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ERCC2—melanoma	1.51e-05	8.34e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PHGDH—melanoma	1.51e-05	8.33e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—LUM—melanoma	1.51e-05	8.33e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—FASN—melanoma	1.5e-05	8.28e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HPSE—melanoma	1.48e-05	8.17e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.48e-05	8.17e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC5A5—melanoma	1.48e-05	8.14e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CUBN—melanoma	1.45e-05	8.02e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CD44—melanoma	1.42e-05	7.86e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GNAQ—melanoma	1.42e-05	7.86e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL2—melanoma	1.41e-05	7.77e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CSPG4—melanoma	1.4e-05	7.75e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SDHD—melanoma	1.4e-05	7.75e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—BSG—melanoma	1.4e-05	7.75e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.4e-05	7.7e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.38e-05	7.63e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP1B1—melanoma	1.37e-05	7.54e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GPAM—melanoma	1.36e-05	7.5e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCB1—melanoma	1.34e-05	7.37e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCB1—melanoma	1.31e-05	7.22e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PRKCA—melanoma	1.23e-05	6.79e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ERCC2—melanoma	1.22e-05	6.73e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.21e-05	6.65e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PRKCA—melanoma	1.2e-05	6.65e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—melanoma	1.2e-05	6.6e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ERCC2—melanoma	1.19e-05	6.59e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CG—melanoma	1.19e-05	6.59e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NRAS—melanoma	1.18e-05	6.52e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PLA2G6—melanoma	1.16e-05	6.38e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PPARG—melanoma	1.15e-05	6.36e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK3—melanoma	1.13e-05	6.24e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCB1—melanoma	1.12e-05	6.21e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK1—melanoma	1.08e-05	5.94e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CD—melanoma	1.05e-05	5.79e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—VCAN—melanoma	1.04e-05	5.73e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ALB—melanoma	1.04e-05	5.72e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PRKCA—melanoma	1.04e-05	5.71e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ERCC2—melanoma	1.03e-05	5.67e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KRAS—melanoma	1.02e-05	5.61e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CG—melanoma	9.63e-06	5.32e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CG—melanoma	9.43e-06	5.21e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CA—melanoma	9.34e-06	5.16e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPARG—melanoma	9.3e-06	5.13e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CB—melanoma	9.15e-06	5.05e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPARG—melanoma	9.11e-06	5.03e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS2—melanoma	9.06e-06	5e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—melanoma	9.04e-06	4.99e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP17A1—melanoma	8.76e-06	4.83e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HRAS—melanoma	8.64e-06	4.77e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.5e-06	4.69e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CD—melanoma	8.47e-06	4.67e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ALB—melanoma	8.36e-06	4.61e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CD—melanoma	8.29e-06	4.58e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GNA11—melanoma	8.27e-06	4.57e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ALB—melanoma	8.19e-06	4.52e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CG—melanoma	8.11e-06	4.47e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—FASN—melanoma	8.1e-06	4.47e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC5A5—melanoma	7.96e-06	4.39e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—melanoma	7.9e-06	4.36e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPARG—melanoma	7.83e-06	4.32e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GNAQ—melanoma	7.69e-06	4.24e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CD44—melanoma	7.69e-06	4.24e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT1—melanoma	7.63e-06	4.21e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CB—melanoma	7.38e-06	4.07e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP1B1—melanoma	7.37e-06	4.07e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS2—melanoma	7.31e-06	4.04e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CB—melanoma	7.23e-06	3.99e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS2—melanoma	7.16e-06	3.95e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CD—melanoma	7.13e-06	3.93e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—melanoma	6.38e-06	3.52e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—melanoma	6.25e-06	3.45e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CB—melanoma	6.21e-06	3.43e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS2—melanoma	6.16e-06	3.4e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCB1—melanoma	6.07e-06	3.35e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PRKCA—melanoma	5.59e-06	3.08e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CA—melanoma	5.58e-06	3.08e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ERCC2—melanoma	5.54e-06	3.06e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—melanoma	5.37e-06	2.96e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKT1—melanoma	4.56e-06	2.51e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CA—melanoma	4.5e-06	2.48e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CA—melanoma	4.41e-06	2.43e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CG—melanoma	4.38e-06	2.42e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPARG—melanoma	4.22e-06	2.33e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CD—melanoma	3.85e-06	2.12e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ALB—melanoma	3.8e-06	2.1e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CA—melanoma	3.79e-06	2.09e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKT1—melanoma	3.68e-06	2.03e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKT1—melanoma	3.6e-06	1.99e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CB—melanoma	3.35e-06	1.85e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS2—melanoma	3.32e-06	1.83e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKT1—melanoma	3.09e-06	1.71e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—melanoma	2.9e-06	1.6e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CA—melanoma	2.04e-06	1.13e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKT1—melanoma	1.67e-06	9.22e-06	CbGpPWpGaD
